Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: ImmuCell(ICCC) the Revenue is 7.186 M (+11.5%);the EBIT is 1.935 M (+239.7%);the EPS is 0.2 (+259.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B11.50%
----
----
EBIT
0.00B239.72%
----
----
EPS
0.2259.90%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf